Verrica Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; …

Biotechnology
US, West Chester [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Verrica Pharmaceuticals Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Verrica Pharmaceuticals Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Verrica Pharmaceuticals Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of VRCA's Analysis
CIK: 1660334 CUSIP: 92511W108 ISIN: US92511W1080 LEI: - UEI: -
Secondary Listings
VRCA has no secondary listings inside our databases.